Elmind Capital, LP
NEW YORK, NY · CIK 2052213 · 13F filing filed 2026-02-17
SEC-registered investment adviser since 2024 · limited partnership
- Assets managed$613.6m
- Staff2 · 1 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds1 (1 hedge) · $613.6m gross assets
- Form ADV · 2026-09-03SEC adviser record
- Legal entityELMIND CAPITAL, LP (US)
$338.9m
reported value
34positions
68.5%in top 10
—no comparable previous quarter
Holdings, Q4 2025
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| COGENT BIOSCIENCES INC COGT | $41.6m12.27% | First filing |
| SYNDAX PHARMACEUTICALS INC SNDX | $39.0m11.50% | First filing |
| VIRIDIAN THERAPEUTICS INC VRDN | $26.7m7.89% | First filing |
| VERA THERAPEUTICS INC VERA | $24.4m7.21% | First filing |
| CELLDEX THERAPEUTICS INC NEW CLDX | $23.5m6.93% | First filing |
| CG ONCOLOGY INC CGON | $20.4m6.03% | First filing |
| BIOCRYST PHARMACEUTICALS INC BCRX | $16.8m4.95% | First filing |
| VAXCYTE INC PCVX | $13.4m3.97% | First filing |
| BEAM THERAPEUTICS INC BEAM | $13.2m3.90% | First filing |
| PHARVARIS N V PHVS | $13.2m3.90% | First filing |
| KALVISTA PHARMACEUTICALS INC KALV | $12.9m3.82% | First filing |
| DYNAVAX TECHNOLOGIES CORP DVAX | $10.5m3.09% | First filing |
| TYRA BIOSCIENCES INC TYRA | $9.2m2.72% | First filing |
| NURIX THERAPEUTICS INC NRIX | $8.7m2.58% | First filing |
| WAVE LIFE SCIENCES LTD 96663EUR | $7.6m2.25% | First filing |
| MBX BIOSCIENCES INC MBX | $6.7m1.96% | First filing |
| KRYSTAL BIOTECH INC KRYS | $5.4m1.60% | First filing |
| UNITED THERAPEUTICS CORP DEL UTHR | $5.4m1.58% | First filing |
| BIOMARIN PHARMACEUTICAL INC BMRN | $4.9m1.44% | First filing |
| RELAY THERAPEUTICS INC RLAY | $4.5m1.34% | First filing |
| TRAVERE THERAPEUTICS INC TVTX | $4.2m1.24% | First filing |
| PROTAGONIST THERAPEUTICS INC PTGX | $3.3m0.98% | First filing |
| CULLINAN THERAPEUTICS INC CGEM | $3.2m0.95% | First filing |
| LIQUIDIA CORPORATION LQDA | $3.1m0.92% | First filing |
| CYTOMX THERAPEUTICS INC CTMX | $3.0m0.88% | First filing |
| UROGEN PHARMA LTD URGN | $2.3m0.69% | First filing |
| IMMUNOCORE HLDGS PLC IMCR | $2.0m0.60% | First filing |
| DESIGN THERAPEUTICS INC DSGN | $2.0m0.58% | First filing |
| ENGENE HOLDINGS INC COM | $1.9m0.56% | First filing |
| ALECTOR INC ALEC | $1.4m0.41% | First filing |
| AMYLYX PHARMACEUTICALS INC AMLX | $1.4m0.40% | First filing |
| APELLIS PHARMACEUTICALS INC APLS | $1.3m0.37% | First filing |
| SUPERNUS PHARMACEUTICALS INC SUPN | $994.0k0.29% | First filing |
| EDGEWISE THERAPEUTICS INC EWTX | $744.5k0.22% | First filing |